JP2000247885A5 - - Google Patents

Download PDF

Info

Publication number
JP2000247885A5
JP2000247885A5 JP1999369310A JP36931099A JP2000247885A5 JP 2000247885 A5 JP2000247885 A5 JP 2000247885A5 JP 1999369310 A JP1999369310 A JP 1999369310A JP 36931099 A JP36931099 A JP 36931099A JP 2000247885 A5 JP2000247885 A5 JP 2000247885A5
Authority
JP
Japan
Prior art keywords
axis represents
improvement rate
focus adjustment
comparative example
control sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1999369310A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000247885A (ja
JP4591728B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP36931099A priority Critical patent/JP4591728B2/ja
Priority claimed from JP36931099A external-priority patent/JP4591728B2/ja
Publication of JP2000247885A publication Critical patent/JP2000247885A/ja
Publication of JP2000247885A5 publication Critical patent/JP2000247885A5/ja
Application granted granted Critical
Publication of JP4591728B2 publication Critical patent/JP4591728B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP36931099A 1998-12-28 1999-12-27 眼精疲労改善用点眼剤 Expired - Lifetime JP4591728B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP36931099A JP4591728B2 (ja) 1998-12-28 1999-12-27 眼精疲労改善用点眼剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP37186398 1998-12-28
JP10-371863 1998-12-28
JP36931099A JP4591728B2 (ja) 1998-12-28 1999-12-27 眼精疲労改善用点眼剤

Publications (3)

Publication Number Publication Date
JP2000247885A JP2000247885A (ja) 2000-09-12
JP2000247885A5 true JP2000247885A5 (enExample) 2007-02-08
JP4591728B2 JP4591728B2 (ja) 2010-12-01

Family

ID=26582097

Family Applications (1)

Application Number Title Priority Date Filing Date
JP36931099A Expired - Lifetime JP4591728B2 (ja) 1998-12-28 1999-12-27 眼精疲労改善用点眼剤

Country Status (1)

Country Link
JP (1) JP4591728B2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2333742C2 (ru) * 2001-01-09 2008-09-20 Луи Йохан ВАГЕНАР Применение декспантенола в композиции для ухода за контактными линзами
FR2863496A1 (fr) * 2003-12-12 2005-06-17 Anben Pharma Composition therapeutique destinee au traitement des troubles de l'accomodation de l'oeil humain
ES2752008T3 (es) 2009-10-30 2020-04-02 Intratus Inc Métodos y composiciones para la liberación sostenida de fármacos
ES2377785B2 (es) * 2010-09-08 2012-09-26 Universidad Miguel Hernández De Elche Composición farmacéutica para el tratamiento del ojo seco.
RU2485939C1 (ru) * 2012-06-19 2013-06-27 Станислав Анатольевич Кедик Офтальмологический препарат в виде глазных капель, содержащий дисульфирам и таурин
CN107028973B (zh) * 2017-05-12 2020-11-24 浙江工贸职业技术学院 一种缓解视疲劳用滴眼液及其制备方法
CN108670952A (zh) * 2018-07-18 2018-10-19 广东三蓝药业股份有限公司 一种牛磺酸滴眼液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
US4975428A (en) * 1988-05-31 1990-12-04 Iolab Corporation Treatment of glaucoma using phosphodiesterase inhibitors
JPH07228532A (ja) * 1993-04-22 1995-08-29 Senju Pharmaceut Co Ltd 水性液剤、その有効成分の溶解性向上方法および安定化方法
CA2205863A1 (en) * 1994-12-19 1996-06-27 Taisho Pharmaceutical Co., Ltd. Liposome eye drops
JP3811970B2 (ja) * 1995-07-27 2006-08-23 大正製薬株式会社 眼精疲労改善点眼液
JPH10203982A (ja) * 1996-07-05 1998-08-04 Takeda Chem Ind Ltd 視機能障害の予防・治療剤
JP4489851B2 (ja) * 1997-02-04 2010-06-23 千寿製薬株式会社 アリールカルボン酸の安定化方法、その安定化剤および安定化されたアリールカルボン酸からなる水性液剤

Similar Documents

Publication Publication Date Title
GB2382950B (en) Communication system and method
JP2004507625A5 (enExample)
JP2004513742A5 (enExample)
CA2443737A1 (en) Lumbar support device
ZA200200609B (en) Process for producing phenyl-alkanes compositions produced thereform, and uses thereof.
JP2002519182A5 (enExample)
AU5311296A (en) 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists
JP2002519061A5 (enExample)
CA2425852A1 (en) Cytomegalovirus intron a fragments
EP1634605A3 (en) treatment of dyslipidemia in a patient having type 2 diabetes
ZA983376B (en) Process for the preparation of flupirtine maleate.
AU2002243766A1 (en) Asymmetric hydrophilic membrane by grafting
FR2789404B1 (fr) Alliage de zirconium et de niobium comprenant de l'erbium comme poison neutronique consommable, son procede de preparation et piece comprenant ledit alliage
JP2001078180A5 (enExample)
WO2003020759A3 (en) A caspase- 8 binding protein, its preparation and use
AU4617600A (en) A process for preparing xanthorrizol from LTiGTcurcuma xanthorrizaLT/iGT roxb. and novel uses of the same
JP2002020525A5 (enExample)
EP1343513A1 (en) Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
EP0781593A3 (de) Verfahren zur Herstellung von Polyetheramidlösungen, unter Verwendung der Polyetheramidlösungen erhältliche dampfsterilisierbare Dialysemembranen sowie Verfahren zur Herstellung dieser Membranen
AU2001298008A1 (en) Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido (2,3-d)pyrimidin-7-ones
JPH1173728A5 (enExample)
EP1123695A3 (en) Oral composition comprising capsules containing keratin
JPH117723A5 (enExample)
WO2001044490A3 (en) A NOVEL METHOD TO PRODUCE HUMAN NATURAL INTERFERON-$g(a)
JP2004091980A5 (enExample)